David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
A Phase 1 clinical trial for people with advanced solid cancers has dosed its first participant with Agenus‘ investigational antibody, AGEN1223, a therapy designed to improve immune system efficiency in ... Read more
Claudin 6, a cell surface protein involved in cell junction formation, may be a promising target for CAR T-cell therapies against solid tumors, according to a proof-of-concept study in mice. ... Read more